Introduction
The prevalence of old age among patients with chronic kidney disease (CKD) is increasing [1] [2] [3] , as is the number of older people in the general population who meet the criteria for CKD [4, 5] . Nephrologists and geriatricians providing care for these patients are often confronted with a complex decision-making process in which reduced kidney function, multimorbidity, polypharmacy, malnutrition, physical and cognitive frailty, limited life expectancy, and reduced quality of life are likely to affect the harm-benefit balance of treatments. This implies that choices around, for example, prescribing angiotensin-converting enzyme inhibitors [4] , preparing for, and starting of renal replacement therapy [6] , or the type of vascular access for maintenance hemodialysis [7] may be deliberated differently compared to treatment decisions in patients who are younger.
Although clinical practice guidelines aim to support treatment decision making, previous research suggested that many chronic disease guidelines may not apply to older and multimorbid patients [8, 9] . This is also true for CKD: Despite the apparent need for a distinct decisionmaking approach, international guidelines addressing overall CKD management in older people are still lacking.
Therefore, the European Renal Association-European Dialysis Transplant Association (ERA-EDTA) and the European Union Geriatric Medicine Society (EUGMS) joined forces to develop such guidelines. As a first step in the development process, European Renal Best Practice (ERBP, the official guideline-writing body of the ERA-EDTA) initiated a study to identify those topics which should be covered by the guidelines. In addition to setting priorities for guideline development, the results of this study will contribute to shaping a European research agenda on how to improve care in older CKD patients.
Methods
The general objective of the new guidelines will be to inform clinical decisions and practices related to managing CKD stage 3b-5 in older patients. It will concern decisions or practices that may be different between older and younger CKD patients or between older patients with and without CKD. With this general objective in mind, we carried out a scoping process to identify and prioritize topics to be addressed in the guidelines (Fig. 1) . We used a broad definition of 'older,' i.e., aged 65 years and above.
Throughout the process, we received input from an international expert panel consisting of eight nephrologists and five geriatricians from Austria, Belgium, Czech Republic, Italy, Romania, Spain, the Netherlands, and the UK; all were recruited via the professional networks of ERBP and EUGMS.
Identifying topics-literature review and open consultation
We first explored those topics relating to CKD care in older people which have been commonly addressed in published studies and guidelines. We searched Cochrane's Central Register of Controlled Trials (CENTRAL) and MEDLINE via Ovid for geriatric guidelines; the syntax is provided in "Appendix 1". Based on title and abstract, two reviewers (SvdV and IN) extracted the primary topic of each publication. They also hand searched the tables of content of geriatrics journals listed in Medscape for the period June 2012-August 2013. The findings of the exploratory review were complemented by the views of the expert panel, which resulted in the identification of a preliminary list consisting of 48 topics ("Appendix 2") in six categories. These were: assessment of renal function and diagnosis of renal impairment; management of symptoms related to CKD stage 3b-5; management of comorbidities; decisions around treatment selection; renal replacement therapy; and conservative (non-dialytic) management of end-stage renal disease.
Standards for guideline development advocate target user involvement in early stages of the development process [10, 11] to optimize guidelines' relevance for clinical practice. Therefore, we organized an open, online consultation among geriatricians and nephrologists. We developed an electronic, English language questionnaire in SurveyMonkey ® that presented all 48 topics from the preliminary list ("Appendix 2"). Within each of the six categories, we asked respondents to select the 50 % of topics that they assigned highest priority for guideline development. At the end of the questionnaire, they could suggest additional topics not yet in the list. Members of our expert panel (BvM, EB, IN, JPM, WvB) pilot-tested the questionnaire for clarity and ease of completion. We disseminated the questionnaire via an undirected email blast to members of the ERA-EDTA, via a link on the EUGMS Web site, and through the professional networks of our experts.
The expert panel then reviewed all suggestions for additional topics, and based on this, we added one category ('General patient management') and five topics (marked as such in Table 1 ), and merged, split, and/or renamed several existing topics. The final topic list consisted of 47 items in seven categories (Table 1) .
Prioritizing topics-expert consensus meeting
To prioritize the 47 topics, twelve of the thirteen experts attended a full-day face-to-face meeting, moderated by a nephrologist who was not a member of the panel (WvB). The meeting followed a nominal group technique structure [12] and included an introductory part and two rounds of priority rating. In the introduction, the moderator presented the priorities as reported in the open consultation ("Appendix 2") and revisited the 47 topics to ensure all experts interpreted them in a similar manner. To align the concept of 'priority' within the panel, we provided cues for [12] characterizing high-priority topics as decisions or practices: (1) that were common in clinical practice; (2) that strongly affected patient outcomes; (3) for which there was uncertainty or disagreement around optimal care; or (4) that may be associated with substantial risk of patient harm (e.g., adverse events) or high costs for the healthcare system [11] .
In the first round of priority rating, individual experts anonymously rated all topics on an ordinal 9-point scale ranging from 1 ('not at all important') to 9 ('critically important'); the topic 'Acute Kidney Injury on CKD' was not included in the priority rating due to an administrative error. The moderator then summarized individual ratings by presenting the median and interquartile range (IQR), accompanied by a bar chart visualizing the rating frequency distribution. Subsequently, the group discussed topics for which priorities varied strongly among experts, and explored explanations for that variation. In round 2, we asked experts to individually and anonymously reconsider their round 1 ratings while taking into account the arguments which arose during the group discussions.
Data analysis
We ranked topics based on the median priority rating (largest to smallest) and its range (smallest to largest) across all experts, as assigned in the second round of the consensus meeting. The range reflected the difference between the highest and lowest ratings assigned by individual experts. To calculate the degree of consensus on a topic's priority, we divided the 9-point rating scale into seven, overlapping 3-point windows (1-3, 2-4, etc., up to 7-9), and counted the number of individual ratings within each window. The highest number of ratings within any of the 3-point windows determined the degree of consensus. This value could range from 4 to 12, with a degree of 12 implying full expert consensus. Differences in consensus degree between rounds were analyzed descriptively. All analyses were performed using IBM SPSS statistics for Windows version 20.0.0.1.
Results
In total, 107 geriatricians and 461 renal clinicians from 82 countries participated in the online consultation; our method of distribution did not allow us to ascertain a response rate. The results are presented in "Appendix 2". Table 1 displays the final priority ranking of topics resulting from the expert consensus meeting. The highest rating in the second round was assigned to 'Screening and referral' (8.5; range 2). Eight topics shared the second highest rating with a median priority score of 8.0 (2) and included topics such as 'Starting dialysis or not'; 'Accurate assessment of renal function'; 'Targets for and management of hypertension'; and 'Detection of causes for and treatment of weight loss and malnutrition.' 'Targets for and treatment of diabetes' received the lowest rating with (3.0; 6).
The number of topics with full consensus increased from three in the first to ten in the second round, of which nine were positioned in the priority top 10. Overall, the mean degree of consensus was 8.98 (SD, 1.58) out of 12 in round 1 and increased to 9.61 (SD, 1.63) in round 2.
Discussion
This study identified and prioritized topics to be addressed in European guidelines for management of CKD in older patients. We identified 47 potential topics through a literature review and by consulting over 500 nephrologists and geriatricians. Through a standardized formal consensus procedure, an expert panel assigned highest priority to 'Screening and referral of older CKD patients.' Table 1 continued
Priorities for guideline development
In keeping with the top priority of screening and referral of older CKD patients, the guideline group intends to develop guidance on the use of prognostic scores to predict death and progression to end-stage renal disease; estimating prognosis was also considered important during the international consensus conference on supportive CKD care organized by KDIGO [13] . The focus for the European guidelines will be on identifying scores to distinguish between patients that may benefit from renal replacement therapy and those who may not [14, 15] . How to integrate such scores in the decision to start dialysis (ranked second in our prioritization) and within a shared treatment decision-making process (ranked 10th) in general has been addressed by other guidelines [13, 16] . Use of prognostic markers to predict the likely course of the patient could enable agreement on criteria for interdisciplinary referral between nephrologists and geriatricians and might overcome potential gaps between treatment paradigms in nephrology and geriatric medicine. Such referral criteria should ultimately be incorporated in guidance on how to organize care for older patients with CKD stage 3b-5, a topic that our expert panel ranked in the top 10. The summary report of the conference on supportive CKD care [13] stated that such care should ideally be delivered by multiprofessional teams, for example, during joint nephrology-geriatric clinics. Likewise, weight loss and malnutrition (assigned second highest priority) might best be addressed in a multidisciplinary setting. Nephrologists tend to focus on dietary needs, whereas geriatricians also address factors such as mobility and cognition which affect ability to shop and prepare food. The advantages of a multiprofessional approach notwithstanding a recent study among European nephrologists and geriatricians suggested that geriatricians are currently seldom involved in dialysis withdrawal decisions, implying a substantial room for improvement in this regard [17] .
Assessment of renal function was also assigned high priority for developing guidance. During group discussions, experts highlighted that the focus of this guidance should be on identifying equations to estimate the glomerular filtration rate, primarily to inform medication dose adjustments in older CKD patients. Suggested tests should be cheap and widely available, and not confounded by factors associated with age, such as reduced muscle mass [18] .
For the final topic selection, the expert group decided against developing guidance for topics already covered by other guidelines. So, despite their high priority, the topics of withholding and withdrawing dialysis were not selected as they both had been addressed previously [13, 16, 20] . This is in line with the international harmonization effort among renal guideline bodies [19] and includes the expert consensus statement on supportive care by KDIGO [13] . KDIGO's guidance development methodology differs from our approach by having expert consensus at its core supported by scoping reviews of the literature, whereas we opted for starting from systematic literature reviews complemented with expert consensus.
Topics such as management of uraemic pruritus were excluded from the prioritization beforehand because guidance was expected to be similar across CKD patients of all ages. The group acknowledged the high prevalence of this symptom [21] and its importance to patients [22] , but deemed it more appropriate to explore the applicability of existing non-renal guidelines [23] or develop pruritus management guidelines targeting CKD stage 3b-5 patients in general.
Strengths and limitations
As part of our methodological approach, we consulted an international group of nephrologists and geriatricians. This broad clinical representation limited the probability of missing topics considered clinically important for the management of CKD in older people; this probability was further decreased by reviewing the literature to inform the online clinician consultation. Furthermore, consulting both stakeholder groups enabled multidisciplinary involvement in the guideline development process, which is advocated for producing balanced guidance [11, 24] .
The expert panel might have assigned high priority to the topic of 'Acute kidney injury on CKD' due to its relatively high incidence in old age, the increasing complexity of risk factors with advancing age, and its poor prognosis for renal function recovery [25] . However, we failed to formally prioritize the topic due to an administrative error. Another limitation of our study is that we did not involve patients or patient representatives. Previous research suggested that clinicians' and patients' perspectives may differ regarding what treatment decisions are important [26, 27] . Thus, involving (representatives of) older patients with CKD in our scoping process might have provided a complementary view of what topics deserve high priority for guideline development.
Future steps
Following the topic selection described in this paper, the guideline development group is now in the process of systematically synthesizing the best available evidence for the high-priority topics. In keeping with previous research suggesting that randomized studies seldom include older patients [28] , the group acknowledged that the strength of the evidence base for providing practice recommendation in this group of patients is sometimes limited. Some of the topics (see Table 1 ) will therefore be addressed as 'pro-con debates' between experts (e.g., dialysis modality selection [29] and optimizing dialysis adequacy [30] ). The systematic approach for evidence retrieval and synthesis will, however, reveal the most prominent knowledge gaps for CKD management in older patients, which will contribute to setting the European agenda for future research. 
Appendix 2
See Table 2 . Do-not-resuscitate/allow-natural-death order (legal order to respect the wish of a patient not to be resuscitated in case of asystole or apnea)
30 (28) 92 (20) 
